-SEC Filing
Vertical Research Downgrades FMC to Hold, Announces $123 Price Target
Vertical Research analyst Kevin McCarthy downgrades FMC (NYSE:FMC) from Buy to Hold and announces $123 price target.
Related Posts
Oppenheimer Downgrades Titan Medical to Perform
Oppenheimer analyst Suraj Kalia downgrades Titan Medical (NASDAQ:TMDI) from Outperform to Perform.
Bloomberg Reported Earlier, Key Iphone Supplier Murata Expects iPhone 14 Orders to Drop on Weak Tech Demand
https://www.bloomberg.com/news/articles/2022-12-07/key-iphone-supplier-expects-orders-to-drop-on-weak-tech-demand?srnd=premium
Cathie Wood’s Ark Sells Another $30M In Tesla, Further Trims Coinbase Stake And Buys More Of This SVOD Stock
Cathie Wood-led investment management firm Ark Invest on Friday sold 26,932 shares — estimated to be worth $30.62 million — in Tesla Inc (NASDAQ: TSLA), booking more profit in the electric vehicle stock as it continues to rise after recently